llm_output,best_matching_ground_truth,best_evaluation,best_score
selective serotonin reuptake inhibitors first-line treatment major depressive disorder,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50
The LLM output is somewhat related to the ground truth, as both statements involve antidepressant medications, but the LLM incorrectly mentions selective serotonin reuptake inhibitors instead of norepinephrine reuptake inhibitors.",0.5
serotonin-norepinephrine reuptake inhibitors (snris) second-line treatment if ssris not effective,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.75
The LLM output is mostly correct as it mentions serotonin-norepinephrine reuptake inhibitors as a second-line treatment, but the ground truth specifically states norepinephrine reuptake inhibitors.",0.75
monoamine oxidase inhibitors (maois) less commonly used over time,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output correctly mentions that monoamine oxidase inhibitors are less commonly used over time, but it does not fully align with the ground truth statement which specifies that pharmacotherapy entails the use of these inhibitors.",0.75
selective serotonin reuptake inhibitors (ssris) first-line treatment major depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct in identifying SSRIs as a common treatment for depression, but it inaccurately states that they are first-line treatment for major depression, while the ground truth mentions psychotherapy as the second most common treatment for acute phase depression.",0.75
tricyclic antidepressants (tcas) comparable to selective serotonin reuptake inhibitors (ssris),Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is not completely accurate as it mentions selective serotonin reuptake inhibitors instead of tricyclic antidepressants, but it does correctly indicate that they are comparable in efficacy.",0.75
"ketamine side effects dizziness, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 0.91
The LLM output is mostly correct but missed mentioning neurotoxicity as a side effect of ketamine.",0.91
"selective serotonin reuptake inhibitors (ssris) side effects sexual and digestive issues, irritability, anxiety, insomnia, and headache",Fluoxetine Side effects Generally acceptable side effect profile,"Score: 0.75
The LLM output correctly identifies some common side effects of Fluoxetine (a SSRI), but misses the fact that it generally has an acceptable side effect profile compared to other medications.",0.75
"monoamine oxidase inhibitors side effects hepatotoxicity, hypertensive crisis leading to lethal intracranial hemorrhage",Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.75
The LLM output adds additional information about hypertensive crisis leading to lethal intracranial hemorrhage, which is not explicitly mentioned in the ground truth statement, lowering the overall correctness score slightly.",0.75
"all antidepressants side effects nausea, vomiting, sexual dysfunction, sedation, priapism, cardiotoxicity",Nefazodone Side effects Rare cases of clinical idiosyncratic hepatotoxicity,"Score: 0.50
The LLM output is incorrect as it provides a generalized list of side effects for all antidepressants, whereas the ground truth specifies a specific side effect for Nefazodone.",0.5
monoamine oxidase inhibitors (maois) specific efficacy in treating depression with atypical features,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output introduces additional context by stating the specific efficacy of MAOIs for atypical features of depression, which may not align with the ground truth statement that they have the same efficacy as tricyclic antidepressants overall.",0.75
selective serotonin reuptake inhibitors (ssris) first-line treatment major depressive disorder (mdd),Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output is mostly correct, but it incorrectly identifies SSRIs as the first-line treatment for major depressive disorder instead of norepinephrine reuptake inhibitors for patients who do not respond to SSRIs.",0.75
monoamine oxidase inhibitors (maois) less commonly used major depressive disorder (mdd),Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output mostly captures the meaning of the ground truth statement but fails to mention that monoamine oxidase inhibitors are indeed a type of pharmacotherapy.",0.75
all antidepressants consistency no significant difference in efficacy among the different classes of antidepressants,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is mostly correct as it highlights the overall consistency in efficacy among different classes of antidepressants, but it does not specifically address the comparison between MAOIs and Tricyclic antidepressants in terms of efficacy.",0.75
electroconvulsive therapy (ect) highly effective specific situations in depression treatment,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies electroconvulsive therapy (ECT) as highly effective in specific situations in depression treatment, but misses the other treatment options mentioned in the ground truth.",0.75
ketamine specific efficacy in treating treatment-resistant major depressive disorder (mdd),"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.50
The LLM output is partially correct as it mentions a specific efficacy in treating major depressive disorder, but it incorrectly states ketamine instead of monoamine oxidase inhibitors.",0.5
electroconvulsive therapy (ect) highly effective major depressive disorder (mdd),Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is mostly correct, but it oversimplifies the effectiveness of electroconvulsive therapy by not specifying that it is effective in some situations and only for the acute phase of depression.",0.75
psychotherapy benefits patients with depression,Luxtherapy Eligible for Those with seasonal and non-seasonal depression. Benefits to sleep deprivation and drug treatments have also been reported,"Score: 0.75
The LLM output captures the main idea that psychotherapy benefits patients with depression, but it is not as detailed or accurate as the ground truth statement.",0.75
"cognitive-behavioral therapy overview based on robust evidence, targets depressed patient's irrational beliefs and distorted cognitions by challenging and reversing them",Cognitive-behavioral therapy For Depressed patientsâ€™ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 1.00
The LLM output accurately conveys the same information as the ground truth statement with minor wording differences.",1.0
monoamine oxidase inhibitors (maois) comparable to tricyclic antidepressants (tcas),Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.95
LLM output is very close to the ground truth with only minor differences in wording.",0.95
"ketamine definition a treatment for resistant unipolar and possibly bipolar depression, and acute suicidal ideation, in intravenous sub-anesthetic doses","Ketamine Has effects on Unipolar, bipolar depression","Score: 0.90
The LLM output is mostly correct as it accurately portrays the effects of ketamine on unipolar and bipolar depression, while also mentioning its effects on acute suicidal ideation at specific doses.",0.9
cognitive-behavioral therapy (cbt) first-line treatment mild to moderate major depressive disorder (mdd),Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.90
The LLM output is highly accurate in conveying the same information as the ground truth, but has a slightly different wording.",0.9
selective serotonin reuptake inhibitors (ssris) first-line treatment major depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The output is mostly correct in identifying SSRIs as a first-line treatment for major depression, but it inaccurately states that it is the second most common treatment, which lowers the overall correctness score.",0.75
physical exercise recommendation depression,Physical Exercise Finding an adjunct to other Anti-depressive treatments,"Score: 0.75
The LLM output captures the main idea of the ground truth but misses the nuances of it being an adjunct to other anti-depressive treatments.",0.75
esketamine definition approved by the united states food and drug administration in march 2019 for treatment-resistant depression,Electroconvulsive therapy Goal Lighten the burden of depression,"Score: 0.75
The LLM output is partially correct as it mentions a different treatment option for depression (esketamine), but does not directly address electroconvulsive therapy and its goal of lightening the burden of depression.",0.75
monoamine oxidase inhibitors (maois) less commonly used depression,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output is mostly correct, but it lacks the specific mention of ""pharmacotherapy"" and the phrase ""ground truth,"" resulting in a slightly lower score.",0.75
transcranial direct current stimulation (tdcs) less effective antidepressants and repetitive transcranial magnetic stimulation (rtms),Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 1.00
The LLM output accurately reflects the ground truth statement, using similar language and conveying the same meaning.",1.0
electroconvulsive therapy (ect) highly effective major unipolar depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output is mostly correct, as it correctly identifies electroconvulsive therapy as an effective treatment for major depression, but it does not mention other acute-phase treatment options for depression.",0.75
interpersonal therapy (ipt) first-line treatment mild to moderate major depressive disorder (mdd),Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.90
The LLM output accurately captures the main idea of the ground truth but lacks specificity in referencing the specific type of psychotherapy.",0.9
monoamine oxidase inhibitors definition a class of antidepressants defined as the first drug for the condition and later classified as monoamine oxidase inhibitor,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output is mostly correct by providing additional details and context, but it does contain some inaccuracies in terms of the classification of monoamine oxidase inhibitors.",0.75
repetitive transcranial magnetic stimulation (rtms) highly effective depression,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct in mentioning repetitive transcranial magnetic stimulation (rTMS) as an effective treatment for depression, but it misses other somatic treatments such as tDCS, VNS, DBS, and magnetic seizure therapy.",0.75
selective serotonin reuptake inhibitors first-line treatment major depression,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output is partially correct as it mentions SSRIs as a first-line treatment for major depression, but it misses the information about norepinephrine reuptake inhibitors being eligible for patients who do not respond to SSRIs.",0.75
"ketamine side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 1.00
The LLM output is an exact match to the ground truth statement.",1.0
"monoamine oxidase inhibitors definition the first drug defined as an antidepressant, later classified as a monoamine oxidase inhibitor",Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.80
The LLM output provides a mostly correct definition and history of monoamine oxidase inhibitors, but contains some unnecessary information and does not directly state that pharmacotherapy entails the use of these inhibitors.",0.8
cognitive behavioral therapy (cbt) first-line treatment depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct in identifying cognitive behavioral therapy (CBT) as a common treatment for depression, but it inaccurately states that it is the first-line treatment, which is not always the case.",0.75
"selective serotonin reuptake inhibitors comparable to tcas, snris, maois",Nefazodone Is comparable to SSRI,"Score: 0.80
The LLM output provides a broader comparison of Nefazodone to various antidepressants, while the ground truth specifically states it is comparable to SSRI, resulting in a slightly lower score.",0.8
interpersonal therapy (ipt) first-line treatment mild to moderate major depressive episode in adults,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.80
The LLM output is mostly correct but could be more specific in indicating that it is depression-focused psychotherapy and not just therapy in general.",0.8
tricyclic antidepressants more effective ssris for hospitalized patients,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.70
The LLM output is somewhat relevant to the ground truth as both statements discuss antidepressants, but the LLM inaccurately states that tricyclic antidepressants are more effective than SSRIs for hospitalized patients, which goes against current medical guidelines.",0.7
selective serotonin reuptake inhibitors (ssris) first-line treatment all depression,Depression Side effect Slower response to treatment,"Score: 0.50
The LLM output does not fully capture the concept of slower response to treatment as a side effect of depression, giving a more general statement about the treatment of depression instead.",0.5
electroconvulsive therapy highly effective major unipolar depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies electroconvulsive therapy as a treatment option for major unipolar depression, but does not mention the other treatment approaches listed in the ground truth statement.",0.75
monoamine oxidase inhibitors treats depression with atypical features,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.80
The LLM output is mostly correct as it accurately identifies monoamine oxidase inhibitors as a treatment for depression with atypical features, but misses some specific details mentioned in the ground truth statement.",0.8
"psycho-educational intervention goal improve the clinical course, treatment adherence, and psychosocial function in patients with depression","Depression-focused psychotherapy Goal To monitor their mood, improve their functioning, understand their symptoms better, and master the practical tools they need to cope with stressful events","Score: 0.80
The LLM output captures the main goals of depression-focused psychotherapy but lacks some specificity compared to the ground truth.",0.8
serotonin-norepinephrine reuptake inhibitors second-line treatment when patients do not respond to ssris,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.85
The LLM output is mostly correct, but it incorrectly refers to norepinephrine reuptake inhibitors as ""serotonin-norepinephrine reuptake inhibitors.""",0.85
"selective serotonin reuptake inhibitors (ssris) side effects sexual and digestive (nausea and loss of appetite), as well as irritability, anxiety, insomnia, and headache",Fluoxetine Side effects Generally acceptable side effect profile,"Score: 0.80
The LLM output correctly identifies common side effects of selective serotonin reuptake inhibitors (SSRIs), but does not mention that the side effect profile of fluoxetine is generally acceptable.",0.8
electroconvulsive therapy (ect) highly effective major unipolar depression,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.75
The LLM output is partially correct as it mentions electroconvulsive therapy (ECT) for major depression, which is related to the topic of depression treatment, but not specific to preventing or treating mild depressive symptoms in the elderly in primary care settings.",0.75
"selective serotonin reuptake inhibitors side effects sexual and digestive issues (nausea and loss of appetite), irritability, anxiety, insomnia, headache",Duloxetine Side effects Lower acceptability,"Score: 0.75
The LLM output includes some correct side effects associated with duloxetine, but also includes side effects not typically associated with this medication, such as sexual and digestive issues.",0.75
selective serotonin reuptake inhibitors (ssris) first-line treatment major depressive disorder,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.50
The LLM output only partially addresses the ground truth statement by mentioning SSRIs, but it does not accurately reflect the intended message about using norepinephrine reuptake inhibitors for patients who do not respond to SSRIs.",0.5
electroconvulsive therapy definition the most effective somatic therapy for depression in some specific situations,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.90
The LLM output is highly accurate in summarizing the ground truth statement but adds additional detail about electroconvulsive therapy being the most effective somatic therapy for depression.",0.9
ketamine specific efficacy in treating treatment-resistant unipolar and bipolar depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.90
The LLM output is very close to the Ground Truth but adds the specificity of ketamine being effective in treating treatment-resistant depression.",0.9
selective serotonin reuptake inhibitors (ssris) side effects sexual and digestive problems,Acceptance and commitment therapy Use Accepting and adjusting to persistent problems,"Score: 0.50
The LLM output is only partially correct as it includes information about side effects of SSRIs but does not directly relate to acceptance and commitment therapy.",0.5
electroconvulsive therapy (ect) results reduces number of hospital readmissions,Electroconvulsive therapy Reduces Number of hospital readmissions,"Score: 0.95
The LLM output is nearly identical to the ground truth statement, with only minor differences in wording.",0.95
monoamine oxidase inhibitors (maois) less commonly used all depression,Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.75
The LLM Output captures the general idea that MAOIs are less commonly used for depression, but it does not specifically mention their use for patients who do not respond to other treatments.",0.75
monoamine oxidase inhibitors (maois) less commonly used due to side effects and dietary restrictions,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output provides additional information about monoamine oxidase inhibitors, but does not directly confirm the statement about pharmacotherapy entailing their use.",0.75
mirtazapine comparable to ssris,Mirtazapine As effective as SSRIs,"Score: 0.90
The LLM output is very close to the ground truth statement, with just a slight difference in wording, but overall conveying the same meaning.",0.9
selective serotonin reuptake inhibitors (ssris) same efficacy as ... for tricyclic antidepressants (tcas),SSRIs Same efficacy as TCAs,"Score: 1.00
The LLM output is exactly the same as the ground truth statement, with proper capitalization and abbreviation usage, resulting in a highly correct score.",1.0
ketamine treats treatment-resistant unipolar and bipolar major depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.85
The LLM output is quite similar to the ground truth statement, but it specifies that ketamine specifically treats treatment-resistant unipolar and bipolar major depression, which is slightly more specific than just stating it has effects on unipolar and bipolar depression.",0.85
"escitalopram more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output incorrectly lists specific medications, but it does correctly identify that antidepressants are being compared in effectiveness.",0.75
mindfulness-based cognitive therapy (mbct) overview combines elements of cbt with mindfulness-based stress reduction,Mindfulness-based cognitive therapy Combines CBT with mindfulness-based stress reduction,"Score: 0.90
The LLM output is quite accurate in summarizing the concept of mindfulness-based cognitive therapy, although it is not an exact match to the original statement.",0.9
electroconvulsive therapy highly effective somatic therapy for depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output is mostly correct in stating that electroconvulsive therapy is a highly effective somatic therapy for depression, but it lacks the inclusion of other acute-phase treatment options mentioned in the ground truth.",0.75
"sertraline more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output identifies specific antidepressants as being more effective than others, which matches the general concept of the ground truth statement, but lacks the specificity of mentioning repetitive transcranial magnetic stimulation as being more effective overall.",0.75
"mirtazapine more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output is mostly correct in stating that mirtazapine is more effective than other SSRIs, but incorrectly includes reboxetine which is not an SSRI.",0.75
"venlafaxine more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies venlafaxine as more effective than other antidepressants, but lacks specificity by including medications that were not mentioned in the ground truth statement.",0.75
escitalopram first-line treatment major depressive disorder,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.25
The LLM output is not correct as it does not accurately reflect the ground truth statement about mindfulness-based cognitive therapy and its goal of reducing antidepressant treatment for high-risk patients.",0.25
antidepressants definition medications that treat major depressive disorder,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.25
The LLM output does not directly address the comparison in the ground truth statement, resulting in a low score for overall correctness.",0.25
major depressive disorder treats selective serotonin reuptake inhibitors (ssris),Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50
The LLM output incorrectly states that major depressive disorder is treated with selective serotonin reuptake inhibitors, when the ground truth is that pharmacotherapy involves norepinephrine reuptake inhibitors, leading to a lower correctness score.",0.5
selective serotonin reuptake inhibitors (ssris) first-line treatment major depressive disorder,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50

The LLM output is not highly correct as it incorrectly mentions selective serotonin reuptake inhibitors instead of norepinephrine reuptake inhibitors as the treatment for major depressive disorder.",0.5
sertraline comparable to escitalopram,Nefazodone Is comparable to SSRI,"Score: 0.50
The LLM output is not highly correct as it incorrectly matches different drugs compared to the ground truth.",0.5
reboxetine less effective other antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies that reboxetine is less effective than other antidepressants, but does not fully match the ground truth statement about the comparative effectiveness of rTMS and antidepressants.",0.75
cognitive-behavioral therapy (cbt) overview involves modifying dysfunctional behavior and cognitions,Cognitive-behavioral therapy For Depressed patientsâ€™ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.75

The LLM output is mostly correct in summarizing cognitive-behavioral therapy, but it lacks the specific focus on depressed patients with irrational beliefs and distorted cognitions that perpetuate depressive symptoms.",0.75
ketamine treats treatment-resistant depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is partially correct as ketamine is a pharmacotherapy used to treat depression, but specifically for treatment-resistant depression rather than the acute phase.",0.75
physical exercise benefits improvement in quality of life and symptom relief for depression,Physical Exercise Benefits Improvements in oneâ€™s quality of life,"Score: 0.75
The LLM output is mostly correct as it expands on the benefits of physical exercise from the ground truth by mentioning symptom relief for depression.",0.75
cognitive-behavioral therapy (cbt) first-line treatment mild to moderate major depressive disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.90
The LLM Output is highly correct as it accurately captures the essence of the Ground Truth statement with minor differences in wording.",0.9
major depressive disorder definition a prevalent psychiatric disorder leading to poor quality of life and impaired functioning,Transcranial direct current stimulation Results Outperforms the simulator by rate of response and remission,"Score: 0.75
The LLM Output provides a general definition of major depressive disorder, which is relevant to the topic but lacks specific details mentioned in the Ground Truth statement.",0.75
electroconvulsive therapy (ect) highly effective major depressive disorder,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies electroconvulsive therapy (ECT) as a highly effective treatment for major depressive disorder, but it does not mention other treatment options or approaches.",0.75
selective serotonin reuptake inhibitors (ssris) first-line treatment major depressive disorder,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.50
The LLM output is only partially correct as it mentions SSRIs as a first-line treatment for major depressive disorder, but does not accurately represent the ground truth statement about Norepinephrine reuptake inhibitors being eligible for patients who do not respond to SSRIs.",0.5
electroconvulsive therapy highly effective major depressive disorder,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies electroconvulsive therapy as a treatment option for major depressive disorder but does not mention the other acute-phase treatment options mentioned in the ground truth.",0.75
ketamine comparable to other antidepressants,Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.50
The score is low because the LLM output does not accurately paraphrase the ground truth statement about monoamine oxidase inhibitors being eligible for patients who do not respond to other treatments.",0.5
"selective serotonin reuptake inhibitors (ssris) side effects sexual and digestive issues, irritability, anxiety, insomnia, headache",Duloxetine Side effects Lower acceptability,"Score: 0.75
The LLM output mentions common side effects of selective serotonin reuptake inhibitors (SSRIs), which is somewhat related to duloxetine but does not specifically mention duloxetine's lower acceptability.",0.75
anxious depression more common than nonanxious depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.50
The LLM output is partially incorrect as it introduces the concept of anxious depression instead of focusing on depression-focused psychotherapy, which is the main treatment for acute phase depression.",0.5
"anxious depression associated with unemployment, less education, more severe depression, concurrent anxiety disorders, melancholic/endogenous features",Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.50
The LLM output contains some relevant information about depression but does not directly address the statement about marital and family therapy treating severe forms of depression associated with medications and hospitalization.",0.5
electroconvulsive therapy (ect) highly effective major unipolar depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly mentions electroconvulsive therapy as a treatment for major unipolar depression, but misses the other acute-phase treatment options listed in the Ground Truth.",0.75
citalopram first-line treatment major depressive disorder,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.25
The LLM output is not correct as it does not accurately reflect the goal of mindfulness-based cognitive therapy for reducing antidepressant treatment.",0.25
"ketamine side effects neurotoxicity, cognitive dysfunction, psychosis, dissociation, cardiovascular symptoms",Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.50
The score is low because the LLM output is completely unrelated to the ground truth statement about monoamine oxidase inhibitors and their side effects.",0.5
anxious depression more common than nonanxious depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is partially correct as it correctly identifies depression as a common issue, but it inaccurately suggests that anxious depression is more common than nonanxious depression.",0.75
monoamine oxidase inhibitors (maois) specific efficacy in treating depression with atypical features,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.80
The LLM output is mostly correct in summarizing the ground truth statement but misses some specific details regarding the symptoms that monoamine oxidase inhibitors are effective in treating.",0.8
"major depressive disorder treatment options pharmacotherapy, depression-focused psychotherapy, combination of medication and psychotherapy, somatic therapy such as electroconvulsive therapy (ect)","Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.95
The LLM output is almost identical to the ground truth, with the only minor difference being the capitalization of ""major depressive disorder"" in the LLM output.",0.95
cognitive-behavioral therapy (cbt) first-line treatment mild to moderate major depressive disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.85
The LLM output is mostly correct but lacks specificity in mentioning cognitive-behavioral therapy as the specific type of depression-focused psychotherapy.",0.85
major depressive disorder associated with high rate of suicidal behavior and mortality,Depression Side effect Suicidal behavior,"Score: 0.80
The LLM output is mostly correct as it accurately expands on the ground truth by mentioning major depressive disorder and mortality, but it doesn't explicitly state that suicidal behavior is a side effect of depression.",0.8
monoamine oxidase inhibitors (maois) second-line treatment patients not responding to several other pharmacotherapies,Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.80
The LLM output captures the essence of the ground truth statement but adds some unnecessary details, making it slightly less correct.",0.8
citalopram first-line treatment major depressive disorder,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.50
The LLM output is partially correct as it mentions a first-line treatment for major depressive disorder (citalopram), but it does not directly address the goal of reducing or stopping antidepressant treatment in mindfulness-based cognitive therapy.",0.5
anxious depression symptom high levels of anxiety,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.50
The LLM output is only partially correct as it mentions anxiety, which is a symptom of depression, but does not accurately reflect the findings of Deep Brain Stimulation in resistant depression patients.",0.5
anxious depression less effective citalopram treatment,"Psycho-education Goal Addresses Issues such as misperceptions about medication, treatment duration, the risk of relapse, and prodromes of depression","Score: 0.75
The LLM output has some relevant keywords related to depression and treatment but does not accurately reflect the content of the ground truth statement.",0.75
anxious depression more common than nonanxious depression,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output is somewhat related to the ground truth as both statements are about differences in symptoms or presentations of different conditions or medications, but the LLM output is not directly linked to the ground truth statement.",0.5
citalopram first-line treatment major depressive disorder in star*d level 1,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output is not very correct as it focuses on citalopram as a first-line treatment for major depressive disorder, which is not directly related to preventing depression among the elderly or treating patients with mild depressive symptoms in primary care.",0.5
anxious depression associated with poor acute outcome than nonanxious depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is somewhat related to the ground truth as both statements mention depression in relation to the acute phase, but the LLM output introduces the concept of anxiety and outcomes which were not part of the initial statement.",0.75
anxious depression less effective citalopram treatment outcome compares to nonanxious depression,Depression Side effect Slower response to treatment,"Score: 0.50
The LLM output includes relevant information about depression, citalopram treatment, and anxiety, but does not directly address the slower response to treatment as seen in the ground truth.",0.5
anxious depression results less likely remission and longer time to occur than those with nonanxious depression,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.80
The LLM output is mostly correct in conveying the idea that anxious depression may have lower remission rates and longer recovery times compared to nonanxious depression, but it does not directly address the comparison of transcranial direct current stimulation results with those of antidepressants and rTMS.",0.8
anxious depression associated with poor acute outcome compared to nonanxious depression following antidepressant treatment,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output conveys a similar message to the ground truth statement, but it introduces additional information about the specific type of depression (anxious versus nonanxious) and the context of acute outcome following antidepressant treatment.",0.75
anxious depression benefits direct and stronger focus in clinical trials for effective treatment strategies,"Depression-focused psychotherapy For Depression, psychosocial difficulties, interpersonal problems, and intra-psychic conflicts","Score: 0.75
The LLM output is mostly correct in recognizing the focus on depression in both statements, but it misinterprets ""anxious depression"" and ""direct and stronger focus"" compared to the ground truth.",0.75
sertraline comparable to escitalopram for treating major depressive disorder with anxious features,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.50
The LLM output is partially correct as it mentions the treatment of major depressive disorder with anxious features, but it does not fully capture the specificity of monoamine oxidase inhibitors in treating atypical features.",0.5
anxious depression associated with greater reduction in anxiety/somatization score but greater residual symptoms of anxiety/somatization at endpoint than those without anxious depression,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.75
The LLM output did not directly address the specific findings of the ground truth regarding deep brain stimulation for resistant depression, but did provide some relevant information about the relationship between anxious depression and symptom reduction.",0.75
anxious depression associated with higher mean qids-sr score at exit and lower raw qids-sr change score and percentage change in qids-sr score than the nonanxious depression group,Psycho-education Goal Educates depressed patients and family members involved in the patientâ€™s life about depression symptoms and management,"Score: 0.75
The LLM output is somewhat relevant to the ground truth as it discusses depression symptoms, but it is not directly addressing the goal of educating patients and family members about depression management.",0.75
"citalopram side effects higher side effect frequency, intensity, burden, and serious adverse event in anxious depression group compared to nonanxious depression group",Depression Side effect Mortality,"Score: 0.80
The LLM output provides a high level of correctness in capturing the relationship between citalopram side effects and depression, but could be improved with more specificity in mentioning mortality.",0.8
"anxious depression more commonly used concomitant treatment for current general medical conditions, associated symptoms of depression (e.g., sleep and agitation), and citalopram's side effects",Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output contains some relevant information about depression and side effects, but it does not directly address the relationship between depression and suicidal behavior.",0.75
